U.S. Health and Human Services (HHS) Secretary Xavier Becerra this morning announced his six appointees to the long-awaited 340B administrative dispute resolution (ADR) board.
The move will be welcomed by the 340B provider community, which has pushed for the creation of the panel since Congress mandated it in the Affordable Care Act over a decade ago. However, it is possible the panel may not be used to review the current petitions filed against six drug manufacturers which have denied or restricted 340B pricing when covered entities use contract pharmacies.
U.S. Health and Human Services (HHS) Secretary Xavier Becerra early this morning announced his six appointees to the long-awaited 340B administrative dispute resolution (ADR) board.
The move will be welcomed by the 340B provider community, which has pushed for the creation of the panel since Congress mandated it in the Affordable Care Act over a decade ago. However, it is possible the panel may not be used to review the current petitions filed against six drug manufacturers which have denied or restricted 340B pricing when covered entities use contract pharmacies.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
